Cargando…

Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis

BACKGROUND: An increasing number of cancer survivors have developed multiple primaries. This study aims to describe the incidence and risk patterns of metachronous second primary cancers (SPCs) in Osaka, Japan. METHODS: Data were obtained from the Osaka Cancer Registry, a population‐based database o...

Descripción completa

Detalles Bibliográficos
Autores principales: Odani, Satomi, Tabuchi, Takahiro, Nakata, Kayo, Morishima, Toshitaka, Kuwabara, Yoshihiro, Koyama, Shihoko, Kudo, Haruka, Kato, Mizuki, Miyashiro, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729047/
https://www.ncbi.nlm.nih.gov/pubmed/34845852
http://dx.doi.org/10.1002/cam4.4457
_version_ 1784626857313828864
author Odani, Satomi
Tabuchi, Takahiro
Nakata, Kayo
Morishima, Toshitaka
Kuwabara, Yoshihiro
Koyama, Shihoko
Kudo, Haruka
Kato, Mizuki
Miyashiro, Isao
author_facet Odani, Satomi
Tabuchi, Takahiro
Nakata, Kayo
Morishima, Toshitaka
Kuwabara, Yoshihiro
Koyama, Shihoko
Kudo, Haruka
Kato, Mizuki
Miyashiro, Isao
author_sort Odani, Satomi
collection PubMed
description BACKGROUND: An increasing number of cancer survivors have developed multiple primaries. This study aims to describe the incidence and risk patterns of metachronous second primary cancers (SPCs) in Osaka, Japan. METHODS: Data were obtained from the Osaka Cancer Registry, a population‐based database of all cancers diagnosed in Osaka. The study subjects were individuals who were first diagnosed with invasive cancers in 16 major cancer sites during 2000–2014, aged 15–79 years, survived at least 3 months, and were followed up for 10 years. We measured incidence rates, cumulative risks, and standardized incidence ratios (SIRs: with the Osaka general population as the referent) of developing SPCs during 3 months to 10 years after the first diagnosis. RESULTS: During 2000–2015, among 418,791 cancer survivors, 24,368 (5.8%) developed SPCs within 10 years of first diagnosis. Males had higher incidence rates than females except among young‐onset survivors (aged 15–39 years). 10‐year cumulative risks among survivors aged 70–79 years (the most dominant age group) were 24.0% (male) and 11.8% (female). 10‐year SIRs were 1.38 (95% CI, 1.36–1.40; male) and 1.44 (95% CI, 1.41–1.48; female) with higher estimates among younger survivors in both sexes. Strong bidirectional associations were observed between oral/pharyngeal, esophageal, and laryngeal cancers. Survivors of any smoking‐related cancers had elevated SIRs of developing smoking‐related SPCs. Similar results were observed for alcohol‐related cancers. CONCLUSIONS: Cancer survivors are at excess risk of developing SPCs compared to the general population. Continued surveillance is warranted to inform survivorship care through risk‐based long‐term care planning and lifestyle‐changing efforts to prevent new cancers.
format Online
Article
Text
id pubmed-8729047
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87290472022-01-11 Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis Odani, Satomi Tabuchi, Takahiro Nakata, Kayo Morishima, Toshitaka Kuwabara, Yoshihiro Koyama, Shihoko Kudo, Haruka Kato, Mizuki Miyashiro, Isao Cancer Med Cancer Prevention BACKGROUND: An increasing number of cancer survivors have developed multiple primaries. This study aims to describe the incidence and risk patterns of metachronous second primary cancers (SPCs) in Osaka, Japan. METHODS: Data were obtained from the Osaka Cancer Registry, a population‐based database of all cancers diagnosed in Osaka. The study subjects were individuals who were first diagnosed with invasive cancers in 16 major cancer sites during 2000–2014, aged 15–79 years, survived at least 3 months, and were followed up for 10 years. We measured incidence rates, cumulative risks, and standardized incidence ratios (SIRs: with the Osaka general population as the referent) of developing SPCs during 3 months to 10 years after the first diagnosis. RESULTS: During 2000–2015, among 418,791 cancer survivors, 24,368 (5.8%) developed SPCs within 10 years of first diagnosis. Males had higher incidence rates than females except among young‐onset survivors (aged 15–39 years). 10‐year cumulative risks among survivors aged 70–79 years (the most dominant age group) were 24.0% (male) and 11.8% (female). 10‐year SIRs were 1.38 (95% CI, 1.36–1.40; male) and 1.44 (95% CI, 1.41–1.48; female) with higher estimates among younger survivors in both sexes. Strong bidirectional associations were observed between oral/pharyngeal, esophageal, and laryngeal cancers. Survivors of any smoking‐related cancers had elevated SIRs of developing smoking‐related SPCs. Similar results were observed for alcohol‐related cancers. CONCLUSIONS: Cancer survivors are at excess risk of developing SPCs compared to the general population. Continued surveillance is warranted to inform survivorship care through risk‐based long‐term care planning and lifestyle‐changing efforts to prevent new cancers. John Wiley and Sons Inc. 2021-11-29 /pmc/articles/PMC8729047/ /pubmed/34845852 http://dx.doi.org/10.1002/cam4.4457 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Odani, Satomi
Tabuchi, Takahiro
Nakata, Kayo
Morishima, Toshitaka
Kuwabara, Yoshihiro
Koyama, Shihoko
Kudo, Haruka
Kato, Mizuki
Miyashiro, Isao
Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
title Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
title_full Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
title_fullStr Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
title_full_unstemmed Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
title_short Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
title_sort incidence and relative risk of metachronous second primary cancers for 16 cancer sites, osaka, japan, 2000–2015: population‐based analysis
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729047/
https://www.ncbi.nlm.nih.gov/pubmed/34845852
http://dx.doi.org/10.1002/cam4.4457
work_keys_str_mv AT odanisatomi incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT tabuchitakahiro incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT nakatakayo incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT morishimatoshitaka incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT kuwabarayoshihiro incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT koyamashihoko incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT kudoharuka incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT katomizuki incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis
AT miyashiroisao incidenceandrelativeriskofmetachronoussecondprimarycancersfor16cancersitesosakajapan20002015populationbasedanalysis